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Membrane rafts (MRs) are clusters of lipids, organized in a “quasicrystalline” liquid-order phase, organized on the cell surface and
whose pattern of molecules and physicochemical properties are distinct from those of the surrounding plasma membrane. MRs
may be considered an eﬃcient and fairly rapid cell-activated mechanism to express or mask surface receptors aimed at triggering
speciﬁc response pathways. This paper reports observations concerning the role of MRs in the control of lung extravascular water
that ought to be kept at minimum to assure gas diﬀusion, supporting the hypothesis that MRs expression is a potential mechanism
of sensing minor changes in the volume of extravascular water. We present the evidence that MRs expression speciﬁcally relates to
signal-transduction processes evoked by mechanical stimuli arising in the interstitial lung compartment when a small increase in
extravascular volume occurs. We further hypothesize that a diﬀerential expression of MRs might also reﬂect the damage to precise
components of the extracellular matrix caused by the perturbation in water balance and thus can trigger a molecule-oriented
speciﬁc matrix remodelling.
1.Introduction
Membrane rafts (MRs) represent specialized portions of the
cell plasma membrane involved in the signalling response to
incomingstimuli.Infact,MRsmaybeconsideredaneﬃcient
and fairly rapid system to express or mask surface receptors
toactivatespeciﬁcintracellularresponsepathways.MRshave
been described in two forms, either ﬂat portions of plasma
membrane, named lipid rafts, or ﬂask-like of about 70nm
in diameter, named caveolae. The latter, besides representing
a receptor platform, also constitutes a potential transcellular
ﬂuid carrier through transcytosis.
This paper reports observations concerning the potential
role of MRs in mechano-sensitive signalling in the control
of lung extravascular water, a key point in the respiratory
function. Indeed, the volume of the extravascular water
ought to be kept at minimum [1] in order to assure the
maximum eﬃciency of the air-blood barrier in the gas
diﬀusion mechanisms. In fact, we were able to describe
how the expression of MRs in pulmonary cells is modiﬁed
when a perturbation of extravascular lung water is caused
either by saline infusion (so-called cardiogenic model of
lung edema, (CE)) or exposure to hypoxia (HE) [2]. Finally,
we will discuss our results considering the phenotype of
animals genetically deprived of an important protein present
in caveolae, namely, Cav-1.
2. Membrane Rafts
The pioneering work of Singer and Nicholson [4]o nb i o -
logical membranes predicted the existence of domains, zones
where the concentration of the components diﬀers from
the surrounding membrane environment. This prediction
implied the possibility that several types of domains could
exist, having diﬀerent patterns of component molecules,
and perhaps even coexisting within the membrane. By
1974, studies on the eﬀects of temperature on membrane
behaviour led investigators to propose the presence of
“clusters of lipids” [5], and by the following year data
were obtained that suggested that these clusters might be2 Journal of Lipids
“quasicrystalline” regions, namely, a liquid-order phase,
surrounded by more freely dispersed and disordered lipid
bilayer [6]. In the last years, several investigations, using
either artiﬁcial (liposomes) or cellular plasma membranes
a n dav a r i e t yo ft e c h n i q u e s[ 7–9] conﬁrmed the existence
of “quasicrystalline” regions, suggesting that organization
in domains is a common feature of biological membranes.
Currently, it is generally accepted that MRs exist within the
plane of the membrane, where the pattern of molecules
and the physicochemical properties are distinct from the
environment [10, 11]. The key diﬀerence between MRs and
the rest of the membrane bilayer is the lipid composition.
In fact, MRs contain cholesterol and sphingolipids at con-
centrations up to 50% higher than rest of the membrane
and the elevated sphingomyelin levels are oﬀset by decreased
levels of phosphatidylcholine [12, 13] so that the total
amount of choline-containing lipids is similar in MRs and
plasma membranes. As a result of tightly packed and more
saturated lipids, plasma membrane regions hosting MRs are
more rigid compared to the rest of the plasma membrane
[12].
2.1. Caveolae and Lipid Rafts. Cholesterol ought to be
abundantly available for the formation of MRs; furthermore,
in some domains the presence of some speciﬁc proteins is
essential to form MRs. One can therefore classify protein-
based membrane domains (i.e., caveolae) and lipid-based
domains (i.e., lipid rafts,) [14]. Figure 1 shows the conven-
tionally agreed structure of caveolae and lipid rafts. Caveolae
are ﬂask-shaped, about 70nm invaginations of the plasma
membrane, organized by the caveolins and the caveolin
family of protein kinase C adaptors [11, 15].
Caveolins attach to the cytosolic face of the membrane
via a hydrophobic hairpin loop and via a scaﬀolding region
that interacts with cholesterol, phosphatidylserine, and PIP2
[16]. Removal or sequestration of cholesterol caused ﬂask-
shaped plasma membrane caveolae to ﬂatten down and
caveolin molecules to disassemble [17].
Lipid rafts (LRs) are small and dynamics membrane
domains held together by lipid-lipid interactions. Although
not necessary for raft formation, proteins could be present
in these domains provided they have aﬃnity for the domain
lipid composition. LRs may diﬀer in terms of protein and
lipid composition as well as in temporal stability.
Both caveolae and LRs are structures involved in mech-
anisms modulating dynamically cell function in relation to
changes in plasma membrane architecture [10, 11]. Such
role is proved by the ﬁnding that the action of several
membrane proteins acting as receptor or second messenger
generator (e.g., tyrosine kinase receptors, mono-Ras, Rap,
hetero-trymeric G proteins, Src-like tyrosine kinases Lck and
Fyn, protein kinase C isoenzymes, GPI-anchored proteins,
and others more) was associated to expression of MRs [18–
21]. This ﬁnding suggested that MRs are spatially organized
on plasma membrane so as to present signalling molecules
in order to promote kinetically favourable interactions for
signal transduction. Conversely, these microdomains can
also separate signalling molecules, to inhibit interactions in
order to damp the signalling responses [22].
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Figure 1: The conventionally agreed structure of caveolae and lipid
rafts (adapted from Galbiati et al. [3]).
Caveolae and LRs exist predominately at the cell surface
as separated structures [23], although they can sometimes
associate with each other. Whenever caveolae are present on
the plasma membrane, LRs are present too, conversely, LRs
may exist without caveolae [24, 25].
Detergent insolubility is the main chemical feature of
MRs. Membranes recovered as low-density fractions after
cold nononic detergent extraction (i.e., Triton X-100),
referred to as detergent-resistant membrane (DRM) rich
in cholesterol, sphingomyelin, and glycolipid, contain MRs
[26, 27].
Many subfractionation techniques based on detergent-
resistant and/or low buoyant densities fractions [28–30]
tend to coisolate caveolae and lipid rafts [23, 31]. Other
detergents, including Lubrol WX, Lubrol PX, Brij 58, Brij 96,
Brij 98, Nonidet P40, CHAPS, and octylglucoside have also
been employed to prepare DRM [32, 33].
Unsurprisingly, the MRs composition diﬀered to some
extent as a function of the detergent used [34]. This ﬁnding
may reﬂect either the diﬀerences in the subfractionation
t e c h n i q u e sa sw e l la st h eh e t e r o g e n e i t yo fM R s ,a ss u g -
gested by immunoelectron [35–37] or immunoﬂuorescence
microscopy [38, 39].
The existence of LRs, as well as their dimensions, has
been controversial owing to the diﬃculty of visualizing
them on cell membranes. A controversy is reﬂected in their
putative size ranging from 5 up to 200nm, that corresponds
to the resolution of optical microscopy. Electron microscopy
provides the required resolution, but not in living cells.
Atomic force microscopy and Forster resonance energy
transfer (FRET) [40] could provide indications on LRs size,
but the direct visualization of LRs, at variance with that of
clusteredproteins,ischallengedbytherapiddiﬀussionofthe
lipid.
Moreover, more recent optical microscopy methods
introduced a superresolution ﬂuorescence microscopy tech-
nique (STimulated Emission Depletion, STED), able toJournal of Lipids 3
decrease the diﬀraction limit thus opening a new strat-
egy to determine lipid diﬀusion [40]. The subdiﬀraction
spot (<50nm) created by STED is able to discriminate
between freely diﬀusing lipids and those that are hindered.
Using this technique, Eggeling demonstrated that phos-
phoglycerolipids, sphingolipids, and GPI-anchored proteins
are transiently (about 10–20ms) trapped in cholesterol-
mediated molecular complexes dwelling within <20nm
diameter areas.
Actually, LRs are deﬁned as dynamics, nanoscale, sterol-
sphingolipid-enriched, ordered assemblies of proteins and
lipids [41]. The metastable resting state of LRs can be
modiﬁed by external signals or by the initiation of mem-
brane traﬃcking events, causing coalescence of LRs into
larger, more stable rafts domains through speciﬁc lipid-lipid,
protein-lipid, and protein-protein interactions, modulated
by actin ﬁlaments.
Recent works [42] have indicated that ceramide is mainly
responsible for LRs coalescence. In fact, the molecules of
ceramide, released within the plasma membranes, spon-
taneously associate and tightly bind to other ceramide
molecules inducing the formation of microceramide-
enriched membranes microdomains that have however the
tendency to spontaneously fuse to form ceramide-enriched
macrodomains (CEM) [42]. The formation of CEM alters
the biophysical membrane properties and moreover pro-
motes the formation of highly stabilized signalling platforms
with greater density of receptors. Several pathways may lead
to ceramide formation although the most common one is
based on the hydrolysis of sphingomyelin catalyzed by acid
sphingomyelinase (ASMase). ASMase is mainly present in
lysosomes and recent works [43] demonstrated that, upon
stimulation, ASMase is translocated from lysosomes onto
the extracellular leaﬂet of the cell membrane, to promote
ceramide production and, consequently, CEM formation.
3.TheLungModeltoEvaluatethe Roleof
Membrane Rafts in Response to Alteration in
LungWaterBalance
The lung parenchyma is composed by diﬀerent cells types
in particular: alveolar and endothelial (about 24 and 30%,
resp.), interstitial cells including ﬁbroblast, lymphocytes,
mast cells, pericytes and plasma cells (about 36%), and
macrophages (about 10%) [44, 45]. The endothelial and
epithelial cells and the intervening basement membrane
constitute the air-blood barrier (Figure 2(a)) that serves gas
diﬀusion between the alveolar spaces and blood [46].
Alveolar epithelium is predominantly comprised of two
cell types, the terminally diﬀerentiated squamous alveolar
epithelial type I cell (AT-I) which constitutes approximately
93% of the alveolar epithelial surface area (estimated to
be 100–120m2, adult human lung) and the surfactant
producing cuboidal alveolar epithelial type II cells (AT-II)
comprising the remaining 7% by surface area [45].
Capillary endothelial cells are much smaller than AT-I,
each covering an average capillary surface area that is only
27% of overall alveolar surface; the total number of capillary
endothelial cells is 3-, 6-fold higher than that of AT-I, while
covering the same approximate total surface area [44, 45].
The presence of plasmalemmal vesicles or invaginations
within the AT-I cell and pulmonary capillary endothelial
cell of rabbit lung has been described, for the ﬁrst time,
by Gil et al. [47, 48]; these workers did not distinguish
between diﬀerent types of vesicles but described the presence
of a high numbers of noncoated vesicles or invaginations
with an average diameter of 70nm. One could make an
estimate of >250 000 plasmalemmal vesicles or invaginations
on the luminal membrane of an ATI cell [49]. However, in
1990 Atwal et al. [50] using electron tracer studies in goat
lung, alluded to the lack of clathrin-coated pits in AT-I. The
majority, but not exclusively all, of the vesicles present in the
alveolar epithelium are the smaller noncoated or smooth-
coated vesicle type that morphologically are recognised as
caveolae. Cav-1 was localized in alveolar epithelial and
pulmonary capillary surfaces of lung tissue; furthermore, by
electron microscopy a greater number of caveolae was found
in endothelial compared to AT-I cells, while none was found
in AT-II cells [51].
Regarding the role of caveolae in pulmonary capillary
surfaces, during recent years a growing body of experimental
data has led to the general consensus that the endothelial
vesicle system can mediate several processes [49, 52–54],
such as transendothelial transport (transcytosis) of macro-
molecules [55–59] and water and modulation of vasomotion
and angiogenesis through inhibition of VEGF [60]a n d
eNOS [61, 62]. The sequestering of eNOS in caveolae
is one of the major mechanisms of eNOS inhibition in
endothelial cells [63, 64], and the dissociation of eNOS from
caveolae is indeed required for its enzymatic activity to allow
synthesis of NO [65]. Moreover, several lines of evidence
now suggest that Cav-1 might play a pro-atherogenic role
in endothelial cells as it is upregulated on LDL exposure
while downregulation is associated with reduced uptake of
oxidized LDL [66, 67].
In conclusion, regulation of endothelial function may be
associated with MRs dissociation or endocytosis. Further-
more, MRs coalescence, mediated by ceramide as a fusogen
product, to generate signalling platforms is now considered
a major mechanism mediating transmembrane signalling in
endothelial cells.
4.WaterBalance inthe Air-BloodBarrier
AscanbeappreciatedfromFigure 2(a),theair-bloodbarrier,
that allows gas diﬀusion processes, appears extremely thin
due to the paucity of water in its three compartments,
namely, the endothelial and epithelial cells as well as the
intervening extravascular interstitial space (the basement
membrane). It is of interest to recall that the minimum
volume of water in the interstitial space reﬂects a powerful
draining action of the lymphatics in face of a very low
permeability of the endothelial barrier; the resulting inter-
stitial pressure is fairly subatmospheric, ∼−10cm H2O, and
microvascular ﬁltration is as low as ∼1 × 10
−4 mL/cm2.
In the alveolar and endothelial cells, cytoplasm volume
is also kept very low, reﬂecting a complex balance between4 Journal of Lipids
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Figure 2: Transmission electron microscopy of the air-blood barrier in control conditions (a), after saline loading to cause cardiogenic lung
edema, (CE) (b) and after hypoxia exposure to cause hypoxic lung edema, (HE) (c). From alveolar (alv) to capillary (cap) surface epithelial
(Epi), basement membrane (BM) and endothelial (Endo) layer are indicated.
plasma membrane channel-mediated water ﬂuxes and shape
assumed by cells due to their strong attachments to adjacent
cells and to the basement membrane.
Fluid ﬁltration across the capillary endothelium is de-
ﬁned by the revisited Starling equation:
Jf = Kf[(Pc−Pi) −σ(Πc −Πi)],( 1 )
where Kf is the ﬁltration coeﬃcient, P and Π refer to
hydraulic and colloid osmotic pressures, subscripts c and i
refer to capillary and interstitial compartments, and σ is the
protein reﬂection coeﬃcient [68]. The ﬁltration coeﬃcient
Kf is equal to the product Lp × S,w h e r eLp is the water
hydraulic permeability and S is the total surface available for
ﬁltration. Lp mostly reﬂects the distribution of small pores,
of the order of 5 nm, in the paracellular regions through
which most of water ﬂows. The protein reﬂection coeﬃcient
σ deﬁnes how easy it is for a the molecule to cross the
endothelium based on the ratio of its radius to that of the
pore. The value of σ varies between 0 (free passage of the
protein) to 1 (full restriction of protein passage) [68]. Under
physiological conditions, Lpis very low and σ is close to 1.
The lung is by nature exposed to conditions causing an
increase in microvascular ﬁltration. This may occur through
an increase in overall surface of ﬁltration (coeﬃcient S,
included in Kf) due to capillary recruitment, normally
associated with increase in cardiac output such as during
exercise and/or exposure to hypoxia. Other important causes
of increase in microvascular ﬁltration are due to an increase
in permeability to water (coeﬃcient Lp, also included in
Kf) and ability of proteins to cross the endothelial barrier
(decrease in σ). These conditions are the consequence of a
loss of integrity of the intercellular matrix structure, due to
proteaseactivityorROSproduction(asinhypoxiaexposure)
[69].
The normal lung, at variance with other organs that
can withstand relatively large increase in tissue hydration
without manifest functional impairment, requires a tight
control on interstitial ﬂuid volume to guarantee respiratory
gas exchange.
At least two mechanisms are operating to control the
volume of lung extravascular water.
The ﬁrst mechanisms of control is based on the remark-
able increase in interstitial pressure (up to about 5cm
H2O) when microvascular ﬁltration increases, in face of
a negligible increase in extravascular (about 5%). Such
increase in pressure buﬀers further ﬁltration and at the same
timeitincreaseslymphaticﬂow.Thus,theﬁrstmechanismof
controlofextravascularwaterisasimplenegativefeedbackas
any increase in interstitial ﬂuid volume acts to limit a further
increase. This mechanisms resides on the integrity of the
interstitial matrix, mostly the proteoglycan component that
provides a low compliance of the extracellular compartment
[70].
The second mechanism depends on the reﬂex precap-
illary vasoconstriction that occurs mainly in edematous
regions [71–73]. Precapillary vasoconstriction avoids an
increase in capillary pressure, a factor favouring edema
formation, particularly in conditions of increased cardiac
output and capillary recruitment.
In parallel with the extreme vasoconstriction in edema-
tous regions, vasodilatation was described in regions that
are still normal. Thus, in presence of in-homogeneities in
regional edema formation, a complex vascular adaptation
occurs in the lung to limit edema formation on one
side and, on the other, to redirect blood ﬂow to lung
regions that assure gas diﬀusion [73]. Experimental proof
has also been provided that severe edema develops when
the fragmentation process exceeds a critical threshold [2]
resulting in loss of rigidity of the matrix and increase in
endothelial permeability.
5.The MechanicalSettingTriggering
the CellularResponse to aPerturbationin
FluidDynamicsinthe Air-BloodBarrier
We will now discuss the potential role of MRs expression
in the early signalling-transduction mechanisms triggered
by abrupt change in interstitial mechanics and structure in
interstitial edema. In particular, we will stress the speciﬁcityJournal of Lipids 5
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Figure 3: Percent changes in the expression of protein markers for
caveolae (caveolin: Cav-1;aquaporin: AQP1)and lipidrafts(CD55)
in cells obtained from lung tissue samples of in vivo models of
cardiogenic (CE) and hypoxic (HE) lung edema.
of MRs expression in relation to the typology of edema and
the time course of matrix fragmentation. In doing, so we will
take into consideration the time course of the remodulation
of lipid moiety of plasma membrane, based on new synthesis
or lipid recycling.
The marked increase in tissue pressure (from about
−10 to about 5cmH2O) in interstitial edema results in an
increase in parenchymal stresses and forces transmitted to
focal points of cell surface by cell-matrix attachments (as
depicted in Figure 7). The molecules mostly involved in cell-
matrix force transmission are those belonging to the pro-
teoglycan family (PGs), namely, heparan-sulphatePGs (0.1–
0.5MDa) mostly present in the basement membrane con-
trolling microvascular permeability and large chondroitin-
sulphatePGs (>0.5MDa) bound to hyaluronan that ﬁlls the
voids of the extravascular space and provides rigidity to
the interstitial matrix. Other small molecular weight PGs
are involved in cell-cell and cell-matrix interactions as well
as in the cytokine network [2] regulating the traﬃco f
the molecules within the interstitial space and promoting
interactions [74, 75].
Diﬀerent time courses of PGs degradation depending on
the type of edema were described [2]. In the so-called “car-
diogenic” model of edema, induced by about 30% increase
in plasma volume, the fragmentation process initially caused
mechanical yielding of the large chondroitin-sulphatePGs
of the matrix, extending subsequently to the heparan-
sulphatePGs of the basement membrane. Conversely, in
a “lesional” type of edema, such as exposure to hypoxia
(12% O2), PGs fragmentation initially involved the heparan-
sulphatePGs of the basement membrane [70], thus leading
to an increase in microvascular permeability to water and
proteins.
We were able to correlate the diﬀerences in the time
sequence of extracellular matrix disorganization to speciﬁc
expression of MRs (caveolae and lipid rafts) as well as to
modiﬁcations of the plasma membrane bilayer composition
in lung cells [76, 77].
Figure 3 shows that in cardiogenic edema there was
an increase in caveolar marker (Cav-1), in line with the
increased density of caveolae, as shown on TEM image in
Figure 2(b); the lipid raft marker (CD55) also considerably
increased. Conversely, in hypoxic lung edema a decrease in
Cav-1 was found, in line with a decrease in caveolar density
(Figure 2(c)), while a considerable increase in CD55 was
observed. The ratio of CD55 over Cav-1 marker was 2.3
in cardiogenic edema, and it increased to 6.6 in hypoxic
edema, indicating a marked increase in LRs expression, at
the expense of caveolae. AQP-1, the marker of aquaporins
that are expressed within caveolae, increased substantially in
cardiogenic edema, but decreased in hypoxic edema, in line
with the corresponding changes in Cav-1.
Thus, diﬀerential expressions of MRs could be related
to diﬀerent pattern of interstitial matrix disorganisation.
Regarding the lipid behaviour, the cardiogenic edema led
to an increase of all principal lipid (cholesterol, GM1, and
phospholipids) present in DRM that obviously include both
caveolae and LRs, conversely no change was observed in
hypoxic lung edema (Figure 4).
As shown in Figure 2(b), the increase in caveolar density
in cardiogenic edema occurs with an increase in surface
area of endothelial cells, particularly on the luminal side.
This can only occur by creating new plasma membrane
because these cells do not possess surface elements pro-
viding unfolding; we thus hypothesized that an increase
in plasma membrane surface could occur through lipid
translocation from cytoplasm to cell surface. Furthermore,
although caveolae are rigid structures, the increase in cell
surface with considerably irregular proﬁle (Figure 2(b))
could be fostered by increased ﬂuidity of the intervening
plasma membrane that reﬂects the modiﬁcations of the
posphatidylcholine/phosphatidylethanolamine and choles-
terol/phospholipid ratios [77]. Cellular deformation favours
vesicular formation and lipid redistribution in the plasma
membrane that, in turn, may activate lipid traﬃcking
between plasma membranes and intracellular lipid stores.
In hypoxia-induced edema, an inhibition of caveolae was
found, while the quantity of lipids remained unchanged
in DRM, supporting the hypothesis that these lipids may
be used for caveolar disassembly and LRs formation, in
line with the increase in the amount of CD55. Since no
changes in total proteins markers of MRs were observed, one
could suppose that these proteins are redistributed between
lipid microdomains and the rest of the plasma membrane.
Finally, on hypoxia exposure the ﬂattening of the cell surface
(Figure 2(c)) was accompanied by a remarkable decrease in
membrane ﬂuidity [46].
6.InVitroModel
Botto et al. [78] using alveolar cells in culture exposed to
mild hypoxia (5%, for 5 and 24h), conﬁrmed the inverse
correlation between caveolae and lipid rafts expression
observed in response to a hypoxic level similar to the in situ
animal model (Figure 5), although the observed changes are
smallerthan those observed in the in situ model. Concerning
the decrease in caveolae, no change in mRNA for Cav-16 Journal of Lipids
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Figure 4: Changes in lipidic composition of lipid microdomains (caveolae and lipid rafts considered together) in cells obtained from lung
tissue samples of in vivo models of cardiogenic (CE) and hypoxic (HE) lung edema. (a) Cholesterol and GM1. (b) SPH: sphingomyelin, PC:
phosphatidylcholine, PS: phosphatidylserine, PI: phosphatidylinositol, PE: phosphatidyethanolamine.
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Figure 5: (a) Percent changes in the expression of protein markers for caveolae (caveolin: Cav-1) and lipid rafts (CD55) in cultured alveolar
cells exposed to 5% oxygen for 5 and 24h. (b) Inverse correlation between Cav-1 and CD55.
was found, as well as in the total content of Cav-1 in total
cellular membrane fraction, suggesting a shift of this protein
to non-detergent-resistant fractions and/or to intracellular
membranecompartments.Immunoﬂuorescencemicroscopy
data supported this last hypothesis as images revealed that,
compared to control (Figure 6(a)), after 5h of hypoxia
exposure, Cav-1 moved away from plasma membrane sur-
face (Figure 6(b)) towards the intracellular compartment
reaching at 24h (Figure 6(b)) a full intracellular localization.
A similar process of internalization for caveolae has been
described in response to physicochemical stimuli [78, 79]a s ,
upon exposure to heat shock or hyperosmotic shock, Cav-1
was found to leave the plasma membrane moving to a region
near the nuclear envelope, while in control cells, Cav-1 was
not seen around the nuclear envelope. Another interesting
observation is that in alveolar epithelial cells exposed to
bleomycin, a chemotherapeutic agent causing lung ﬁbrosis,
Cav-1 were conﬁned to the cytoplasm [80]. The modulation
of caveolin traﬃc from perinuclear region to/from plasma
membrane may be part of speciﬁc signalling transduction
processes.
Similarly to Cav-1, also in the case of CD55 its total con-
tent in total cellular membrane fraction was unchanged,
while it increased in DRM, suggesting a shift from nonraft
membrane portions.
Sprenger et al. [81] demonstrated that LRs and caveolae
proteomes are biochemically separated in endothelial cells
and stressed the importance of a precise rafts-caveolae
ratio to balance their interaction in controlling membrane
traﬃcking, transduction and growth.
7. Consideration on the Cav-1 (−/−) Model
In Cav-1 (−/−) knockout mice, severe pathomorphological
defects are observed in the lung, such as a thickening of
the basement membrane in the air-blood barrier, consistentJournal of Lipids 7
(a) (b) (c)
Figure 6: Immunoﬂuorescence microscopy images showing the localization of Cav-1 in the plasma membrane in normoxic condition (a)
and its progressive translocation within the cytoplasm after 5 and 24h of hypoxia exposure ((b) and (c), resp.).
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Figure 7: Possible model of lung cellular response to an increase in interstitial pressure caused by an increase in extravascular water not
exceeding 5–10% (interstitial edema). Cell signaling is activated by mechanical stimulation through rigid links (collagen I, B-integrin,
cytoskeleton), chemical/mechanical activation of the MRs by fragments of matrix and basement membrane (perlecan, versican, resp.). The
activation of ASMase leads to ceramide formation that modulates diﬀerent intracellular signaling pathways.
with edema formation and hypercellularity [82]. On the
average, most lung regions loose the normal morphology
with a marked reduction of the air/tissue volume ratio.
The increased amount of extravascular water in Cav-1
(−/−) knockout mice can be interpreted with increased
microvascular permeability due to eNOS whose action was
not inhibited by caveolin [83].
The role of endothelial cells as mechanotransducer, is
conﬁrmed by the paper of Yu et al. [84]. In this work, using
Cav-1 (−/−) knockout mice, the authors established that
caveolae and Cav-1 are required for short- and long-term
mechanotransduction in blood vessels. In fact, the endothe-
lium lacking caveolae was unable to couple changes in blood
ﬂow with proportional vascular remodeling, suggesting that
caveolae might represent an initial ﬂow mechano-sensor
directly regulated by luminal blood ﬂow.
8. A Model for LM Mechanotransduction-
SignallingResponse
Themechanismsbywhichcellssensemechanicalstimuliand
transform the signals into intracellular biochemical signals
have not been fully characterized and the most intriguing
property of the caveolin/caveolae system is its involvement in
mechanosensing. The two speciﬁc questions to be answered
are (1) how MRs functions are regulated by mechanical
and biochemical perturbations of the pericellular microen-
vironment and (2) what are the relationships between these8 Journal of Lipids
stimuli and the speciﬁc changes in lipid composition of MRs
and plasma membrane.
Endothelial and epithelial cells are highly deformed in
vivobeingkeptinaﬂatshapeduetotheirstrongattachments
to the neighbouring cells and to the extracellular matrix.
According to the “tensegrity” concept [85], their “hard-
wired” cytoskeleton might keep them in a good position
to respond promptly to forces/pressures applied on their
surface or transmitted through the cytoskeleton [85]. In
fact, the cytoskeleton has an established role in mechano-
transduction being able to transmit and modulate tension
within the cell via focal adhesion sites, cellular junctions,
and the extracellular matrix [86, 87]. Endothelial cells are
equipped with numerous receptors, such as CD31, that
allow them to detect and respond to mechanical forces.
Furthermore, changes in lipid composition of the bilayer
[88] may represent the biochemical background to activate
the signal-transduction machinery that includes MRs [89].
One can interpret the inverse correlation between caveolae
and lipid rafts in response to diﬀerent types of edema as
a relatively fast response of the signalling system, necessary
to face the cellular/extracellular microenvironment pertur-
bation and trigger the appropriate countermeasures.
Changes in cytoplasm volume, such as those observed in
response to the two types of edema, also represent a sign of
cellular activation [46]. The two edema models substantially
diﬀer in terms of proteoglycans fragments that may act as
speciﬁc modulators of matrix remodelling/deposition and in
cell-matrix and cell-cell interaction [90].
Cytoplasm volume changes are due to transmembrane
ion ﬂuxes that are part of cell transduction-signalling
mechanisms [91]. In fact, the permeability of mechano-
sensitive ion channels was found to vary on changing the
composition of the lipid bilayer in the microenvironment
surrounding the channels. Several channels have been shown
to be associated with caveolae [92], such as E-Nac in AT-I
cells.
We will now discuss the potential role of ceramide,
considered as a second messenger whose involvement in
perturbation in lung water balance has been reported
[93]. Ceramide was found to activate catabolic cytokines
and matrix-metalloproteinase expression, thus promoting
metabolic pathways leading to extracellular matrix remod-
ulation and cell apoptosis [94].
In Figure 7, we suggest a possible model of lung cellular
response to an increase in interstitial pressure caused by an
increase in extravascular water not exceeding 5–10% (inter-
s t i t i a le d e m a )a sw e l la st op r o d u c t so fm a t ri xf r a gm e n t a t i o n .
The mechanical stress triggers cell signalling through rigid
mechanical links (collagen I, β-integrin, cytoskeleton) and
chemical/mechanical activation of the MRs by fragments of
proteoglycans [2] from the matrix (versican) and from the
basement membrane (perlecan). The activation of ASMase
leads to ceramide formation that, in turn, may cause matrix
remodeling and tissue repair or, conversely, matrix degra-
dation and cell apoptosis as in degenerative lung disease.
Interestingly, on clinical ground, interstitial edema ought to
be considered as borderline condition between recovery or
development of lung disease.
9. Methods
9.1. MRs Isolation
9.1.1. In Vivo Models. The experiments were carried out on
adult New Zealand rabbits [2.5 ± 0 . 5( S D )k gb o d yw t ]
subject to cardiogenic (CE, saline infusion type) or hypoxic
(HE) lung edema. Animals were sacriﬁced, homogenates of
thelungtissuewerecentrifuged,andsupernatantsweresaved
to obtain plasma membrane fractions (PM). PM were used
to prepare the plasma membrane detergent resistant fraction
(DRM), containing MRs [46, 76].
9.1.2. In Vitro Model. A549 cells lung epithelial cells were
kept in normoxia (21% O2) up to conﬂuence and thereafter
w e r ee x p o s e dt oh y p o x i a( u pt o2 4 h5 %O 2,3 7 ◦C). Cells
kept in control and exposed to hypoxia were washed twice,
harvested in PBS solution and centrifuged. The pellets were
used to prepare the membrane detergent resistant fraction
(DRM) [76].
9.1.3. Lipid Analysis. Phospholipids, sphingomyelin, choles-
terol, and glycosphyngolipid GM1 were extracted from
DRMs and separated by HPTLC; detection and quantiﬁca-
tion were performed as described [46, 76].
9.1.4. Protein Analysis. Cav-1, AQP1, and CD55 in DRM
were determined by sequential EF-10% SDS-PAGE and
Western blotting. Immunoblot bands were analysed and
quantiﬁed by Kodak Image Station 2000R interfaced with a
Kodak Molecular Imaging Software [46, 76].
9.1.5. Statistical Analysis. Biochemical determinations were
repeated three times for each animal. Biochemical results
were expressed as means ± SD, averaging data from the
diﬀerent animals. The signiﬁcance of the diﬀerences among
groups was determined using one-way ANOVA and t-test.
9.1.6. Immunoﬂuorescence Analysis. Conﬂuent cells were
ﬁxed with methanol at −20◦C for 10min and incubated
with primary antibody Rabbit polyclonal Anti-Cav-1 (BD
Italia SpA) diluted 1:500 in blocking buﬀer for 2hrs at
R T .A f t e rw a s h i n gt h r e et i m e sw i t hH SB u ﬀer, cells were
incubated with antirabbit Alexa 488-Conjugated secondary
antibody (Molecular Probes) diluted 1:100 in blocking
buﬀer at RT for 1hr. Cells were then washed three times
with HS buﬀer and twice with LS Buﬀer, incubated with
DAPI for 5min and mounted with glycerol 95% in PBS.
This protocol was applied in control condition and after
and 24hr of hypoxia exposure. Video confocal microscopy
was performed using ViCo system on an inverted Nikon
ECLIPSE TE2000E microscope with 60X objective.
9.1.7. Transmission Electron Microscopy. Transmission elec-
tron microscopy was performed on lung tissue samples to
carry a morphometric analysis to determine the density of
caveolae in lung cells of the air-blood barrier [95].Journal of Lipids 9
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